According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal allergy, eczema or food allergy.

Joan Smith spent almost 40 years believing she suffered from severe allergies. Medical professionals frequently dismissed her ...

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.

The following is a summary of “Prevalence of Mast Cell Activation Disorders and Hereditary Alpha Tryptasemia Amongst POTS and ...

Because of the often nonspecific nature of MCL, diagnostic efforts need to be better streamlined to reduce the risk of misdiagnosis.

Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your ...

Raquel Rodriguez has lost many months of her WWE career due to her skin condition flaring up at very inopportune times. RAW ...

Raquel Rodriguez recently opened up about a skin condition during an interview on INSIGHT with Chris Van Vliet.

Blueprint Medicines' strong pipeline and Ayvakit growth make it promising. Read why BPMC stock is rated "Hold" due to high ...

Preclinical Work Advancing with Plans to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the Clinic Later This Year Phase 1 Trial for SEP-631, MRGPRX2 NAM Program for ...

Plans to build a new mobile phone mast close to a children's playground ... whilst still being located in the cell area in a way that it can replicate the coverage footprint of the existing ...